keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DCDAPH (Compound 2c), a novel smart near-infrared fluorescence (NIRF) probe, efficiently detects β-amyloid (Aβ) plaques with an excitation/emission wavelength (λ ex /λ em) of 597/665 nm in PBS. It demonstrates high affinity for Aβ aggregates, exhibiting a dissociation constant (Kd) of 27 nM and an inhibition constant (Ki) of 37 nM. Furthermore, DCDAPH exhibits favorable blood-brain barrier permeability, qualifying it as a suitable agent for both in vitro and in vivo detection of Aβ plaques [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | DCDAPH (Compound 2c), a novel smart near-infrared fluorescence (NIRF) probe, efficiently detects β-amyloid (Aβ) plaques with an excitation/emission wavelength (λ ex /λ em) of 597/665 nm in PBS. It demonstrates high affinity for Aβ aggregates, exhibiting a dissociation constant (Kd) of 27 nM and an inhibition constant (Ki) of 37 nM. Furthermore, DCDAPH exhibits favorable blood-brain barrier permeability, qualifying it as a suitable agent for both in vitro and in vivo detection of Aβ plaques [1]. |
Molecular Weight | 249.31 |
Formula | C16H15N3 |
CAS No. | 125113-96-4 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DCDAPH 125113-96-4 inhibitor inhibit